Sigma-Aldrich today announced the launch of its TransPlex(R) Whole Transcriptome Amplification (WTA2) technology. TransPlex technology is believed to be the fastest, most sensitive and robust method available for amplifying total RNA from a variety of sample tissue sources such as animals, plants, and microorganisms.
Carbon nanotubes have significant potential for delivering both imaging and therapeutic agents to tumors, but there is still a need to better quantify how well these rolled-up sheets of graphite can target tumors. Now, t...
Today Percepta Associates Inc. announced the release of MicroRNA Analysis in North America: A research market report for life science tool providers. This report presents an overview of current technologies in use, suppl...
As part of its commitment to promote basic research in the life sciences, Applied Biosystems Inc. today announced the creation of a grant program for genomic, epigenomic and transcriptome studies. The $10K Genome Grant P...
A meeting for cooperative planning between China and Canada on International Barcode of Life Project (iBOL) was held on 14 October in Beijing. The iBOL, a consortium of more than 1,000 scientists from 25 countries, has one overarching goal - to assemble the sequence library and the technology necessary to identify organisms rapidly and inexpensively.
Viruses -- long regarded solely as disease agents -- now are being used in therapies for cancer. Concerns over the safety of these so-called oncolytic viruses stem from their potential to damage healthy tissues. Now Mayo...
The University of Connecticut has opened a nanobionics "clean room" that will allow university scientists to make cutting-edge devices, such as a tiny, implantable glucose sensor that could help more than 20 mi...
Calvert Research, LLC (a Calvert Holdings, Inc. company) and Auburn University announced today a joint research project entitled, Targeted Drug Delivery. Undertaken through Auburn University College of Veterinary Medicin...
Recent years have witnessed the rapid development of China's nano-science and technology with widespread influence. On January 2008, a proposal to convene a Sino-US symposium on nano-medicine and nano-biology was joi...
Every copy of the human genome generally consists of the same set of genes, but considerable variability exists between individuals at the sequence level. Variations can include single nucleotide polymorphisms (SNPs), in which one DNA base is substituted for another; or copy-number variations (CNVs), in which entire blocks of gene sequence are deleted or duplicated. Individual variations can alter the function or activity of affected genes, and thus have important health implications.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.